Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Post by Danno13on Dec 06, 2023 12:49pm
132 Views
Post# 35771291

CBD

CBDYou’re invited to a live briefing today at 4:30 pm ET featuring leading voices on the need for Congress to regulate CBD products as dietary supplements. The briefing will feature an authoritative, in-depth discussion on the current status of CBD and the best path forward, followed by a Q&A with audience questions. Panelists from the Coalition for Access Now, U.S. Pain Foundation and Balanced Veterans Network will speak to the beneficial role that CBD plays in the lives of millions of Americans from all walks of life. Panelists from ToxStrategies LLC and Dentons will discuss key scientific and legal considerations for future FDA regulation of CBD products as dietary supplements.  The panelists, who will have just come from meetings on Capitol Hill, include:
  • Jennifer Baxter, Executive Director, Balanced Veterans Network
  • Kelly Fair, Strategic Advisor, ONE HEMP and US Cannabis and Hemp Group Partner, Dentons
  • Paige Figi, Executive Director, Coalition for Access Now
  • Nicole Hemmenway, CEO, U.S. Pain Foundation
  • Dr. Rayetta Henderson, Foods & Consumer Products, Senior Managing Scientist, ToxStrategies LLC
Register here to watch the briefing live (or to receive a recording). The opportunity has arrived for substantive federal CBD policy reform in Congress. The ONE HEMP briefing is part of a broader effort to urge the committees of jurisdiction in Congress – House Energy and Commerce and Senate HELP – to move ahead with marking up legislation. Hemp and CBD producers, and the millions of Americans who rely on their products, will all benefit from a clear regulatory framework for CBD products. About ONE HEMP: With an unwavering commitment to science and consumer safety, ONE HEMP is an industry coalition comprised of respected voices and CBD market leaders whose concerted efforts are aimed at equipping Congress and the FDA with the knowledge and support required to pass sensible guidelines for a standardized CBD industry. Learn more at www.onehemp.org.
<< Previous
Bullboard Posts
Next >>